Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16624914 | 0.93 | SMN1; SMN2 (0.47) | SMN1; SMN2LMNANPC1RAB9AGAA | |
| SCHEMBL16624910 | 0.89 | SMN1; SMN2 (0.46) | SMN1; SMN2LMNANPC1RAB9AGAA | |
| SCHEMBL16624901 | 0.88 | F2 (0.46) | LMNANPC1RAB9ACYP3A4TSHR | |
| SCHEMBL16624922 | 0.86 | CYP3A4 (0.41) | SMN1; SMN2NPC1RAB9ACYP3A4MAPK1 | |
| SCHEMBL19071630 | 0.85 | CYP3A4 (0.39) | LMNANPC1RAB9ACYP3A4CYP2C19 | |
| SCHEMBL16624908 | 0.81 | KCNA5 (0.53) | SMN1; SMN2NPC1RAB9ACYP3A4CYP2C19 | |
| SCHEMBL16624893 | 0.81 | MEN1 (0.48) | SMN1; SMN2LMNANPC1CYP3A4TSHR | |
| SCHEMBL16624916 | 0.80 | L3MBTL1 (0.46) | SMN1; SMN2LMNANPC1RAB9ACYP3A4 | |
| SCHEMBL16624891 | 0.78 | LMNA (0.45) | SMN1; SMN2LMNANPC1RAB9ACYP3A4 | |
| SCHEMBL19071597 | 0.78 | SMN1; SMN2 (0.43) | SMN1; SMN2LMNANPC1RAB9AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2864284-B1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO KGAA (DE) | 2017-07-05 | — | — | EP | disclosed |
| US-9458081-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| US-9458081-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | SMN1; SMN2 2584/4885LMNA 1058/4885NPC1 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.